215 related articles for article (PubMed ID: 37240076)
1. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Nakashima M; Uchimaru K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
[TBL] [Abstract][Full Text] [Related]
2. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
3. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
Ganapathi KA; Nicolae A; Egan C; Geng H; Xi L; Pack SD; McFadden JR; Raffeld M; Jaffe ES; Pittaluga S
Br J Haematol; 2024 May; 204(5):1862-1871. PubMed ID: 38613165
[TBL] [Abstract][Full Text] [Related]
4. CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.
Nakashima M; Yamochi T; Watanabe M; Uchimaru K; Utsunomiya A; Higashihara M; Watanabe T; Horie R
Clin Cancer Res; 2018 Nov; 24(21):5445-5457. PubMed ID: 30068708
[No Abstract] [Full Text] [Related]
5. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
Maeda N; Muta H; Oflazoglu E; Yoshikai Y
Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.
Nakashima M; Utsunomiya A; Watanabe T; Horie R; Uchimaru K
Cancer Sci; 2023 Apr; 114(4):1556-1568. PubMed ID: 36541483
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression.
Ohtsuka E; Kikuchi H; Nasu M; Takita-Sonoda Y; Fujii H; Yokoyama S
Leuk Lymphoma; 1994 Oct; 15(3-4):303-10. PubMed ID: 7866279
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.
Gualco G; Chioato L; Weiss LM; Harrington WJ; Bacchi CE
Am J Clin Pathol; 2009 Jul; 132(1):28-33. PubMed ID: 19864230
[TBL] [Abstract][Full Text] [Related]
11. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.
Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE
Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583
[TBL] [Abstract][Full Text] [Related]
12. CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1.
Hori M; Mitsuhashi S; Kobayashi T; Nagasawa T; Mori N; Miwa M; Abe T
Br J Haematol; 1994 Oct; 88(2):419-20. PubMed ID: 7803296
[TBL] [Abstract][Full Text] [Related]
13. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
Rinaldi I
Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
15. CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area.
Takeshita M; Ohshima K; Akamatsu M; Ohgami A; Kikuchi M; Suzumiya J; Uike N; Okamura T; Nakayama J
Hum Pathol; 1995 Jun; 26(6):614-9. PubMed ID: 7774890
[TBL] [Abstract][Full Text] [Related]
16. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
17. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Ramos CA; Ballard B; Zhang H; Dakhova O; Gee AP; Mei Z; Bilgi M; Wu MF; Liu H; Grilley B; Bollard CM; Chang BH; Rooney CM; Brenner MK; Heslop HE; Dotti G; Savoldo B
J Clin Invest; 2017 Sep; 127(9):3462-3471. PubMed ID: 28805662
[TBL] [Abstract][Full Text] [Related]
19. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
20. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
